These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 31853283)

  • 21. Incidence, Clinical Characteristics, and Impact of Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement.
    Vilalta V; Asmarats L; Ferreira-Neto AN; Maes F; de Freitas Campos Guimarães L; Couture T; Paradis JM; Mohammadi S; Dumont E; Kalavrouziotis D; Delarochellière R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2523-2533. PubMed ID: 30573061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of nicorandil against cerebral injury in a swine cardiac arrest model.
    Zhu F; Zhong X; Zhou Y; Hou Z; Hu H; Liang L; Chen J; Chen Q; Ji X; Shang D
    Exp Ther Med; 2018 Jul; 16(1):37-44. PubMed ID: 29977355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: a patient-level pooled analysis.
    Lee JM; Kato D; Oi M; Toyofuku M; Takashima H; Waseda K; Amano T; Kurita A; Ishihara H; Lim WH; Doh JH; Nam CW; Tanaka N; Koo BK; Tanaka N
    EuroIntervention; 2016 Jun; 12(2):e208-15. PubMed ID: 27290680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.
    O'Donoghue ML; Morrow DA; Cannon CP; Jarolim P; Desai NR; Sherwood MW; Murphy SA; Gerszten RE; Sabatine MS
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological preconditioning and postconditioning with nicorandil attenuates ischemia/reperfusion-induced myocardial necrosis and apoptosis in hypercholesterolemic rats.
    Li W; Wu N; Shu W; Jia D; Jia P
    Exp Ther Med; 2015 Dec; 10(6):2197-2205. PubMed ID: 26668616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.
    Chen C; Fu X; Li W; Jia X; Bai S; Geng W; Xing K
    Exp Ther Med; 2015 Sep; 10(3):1059-1065. PubMed ID: 26622439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study).
    McClelland RL; Jorgensen NW; Budoff M; Blaha MJ; Post WS; Kronmal RA; Bild DE; Shea S; Liu K; Watson KE; Folsom AR; Khera A; Ayers C; Mahabadi AA; Lehmann N; Jöckel KH; Moebus S; Carr JJ; Erbel R; Burke GL
    J Am Coll Cardiol; 2015 Oct; 66(15):1643-53. PubMed ID: 26449133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced oxidative stress in STEMI patients treated by primary percutaneous coronary intervention and with antioxidant therapy: a systematic review.
    Ekeløf S; Jensen SE; Rosenberg J; Gögenur I
    Cardiovasc Drugs Ther; 2014 Apr; 28(2):173-81. PubMed ID: 24532094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble CD40 ligand release in patients with stable coronary artery disease during elective stent implantation: effect of drug-eluting stent over bare metal stent.
    Dündar C; Kızılırmak F; Tigen K; Izgi A; Karaahmet T; Pala S; Oduncu V; Erkol A; Bulut M; Kırma C
    Turk Kardiyol Dern Ars; 2013 Dec; 41(8):675-82. PubMed ID: 24351940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox balance and cardioprotection.
    Tullio F; Angotti C; Perrelli MG; Penna C; Pagliaro P
    Basic Res Cardiol; 2013 Nov; 108(6):392. PubMed ID: 24158692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicorandil inhibits hypoxia-induced apoptosis in human pulmonary artery endothelial cells through activation of mitoKATP and regulation of eNOS and the NF-κB pathway.
    Wang H; Zuo X; Wang Q; Yu Y; Xie L; Wang H; Wu H; Xie W
    Int J Mol Med; 2013 Jul; 32(1):187-94. PubMed ID: 23670355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress and pathological changes after coronary artery interventions.
    Juni RP; Duckers HJ; Vanhoutte PM; Virmani R; Moens AL
    J Am Coll Cardiol; 2013 Apr; 61(14):1471-81. PubMed ID: 23500310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory.
    Jang HJ; Koo BK; Lee HS; Park JB; Kim JH; Seo MK; Yang HM; Park KW; Nam CW; Doh JH; Kim HS
    Eur Heart J; 2013 Jul; 34(27):2055-62. PubMed ID: 23396491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions.
    van Dijk RA; Kolodgie F; Ravandi A; Leibundgut G; Hu PP; Prasad A; Mahmud E; Dennis E; Curtiss LK; Witztum JL; Wasserman BA; Otsuka F; Virmani R; Tsimikas S
    J Lipid Res; 2012 Dec; 53(12):2773-90. PubMed ID: 22969153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
    Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
    Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
    Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
    Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An important role for VCAM-1, but not for ICAM-1 in restenosis following coronary stent implantation.
    Bayata S; Arıkan E; Yeşil M; Postacı N; Taş A; Köseoğlu M
    Anadolu Kardiyol Derg; 2010 Oct; 10(5):405-9. PubMed ID: 20929696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of stent implementation on plasma levels of asymmetric dimethylarginine in patients with or without ST-segment elevation acute myocardial infarction.
    Ajtay Z; Németh A; Sulyok E; Cziráki A; Szabados S; Martens-Lobenhoffer J; Awiszus F; Szabó C; Bode-Böger SM
    Int J Mol Med; 2010 Apr; 25(4):617-24. PubMed ID: 20198311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracoronary nicorandil prior to reperfusion in acute myocardial infarction.
    Miyazawa A; Ikari Y; Tanabe K; Nakajima H; Aoki J; Iijima R; Nakayama T; Hatori M; Nakazawa G; Tanimoto S; Onuma Y; Hara K
    EuroIntervention; 2006 Aug; 2(2):211-7. PubMed ID: 19755263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon.
    Kawai Y; Hisamatsu K; Matsubara H; Dan K; Akagi S; Miyaji K; Munemasa M; Fujimoto Y; Kusano KF; Ohe T
    Eur Heart J; 2009 Apr; 30(7):765-72. PubMed ID: 19276198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.